CytoDyn Inc. Quarterly report pursuant to Section 13 or 15(d)

Stock Options and Warrants (Tables)

6 Months Ended

Nov. 30, 2018

The following table represents stock option and warrant activity as of and for the six months ended November 30, 2018:


	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years		Aggregate Intrinsic Value
Options and warrants outstanding - May 31, 2018		132,385,269		$	0.80		3.78	$	3,673

Granted		33,483,124			0.69		—		—
Exercised		—			—		—		—
Forfeited/expired/cancelled		(10,031,717	)		0.75		—		—

Options and warrants outstanding - November 30, 2018		155,836,676			0.78		3.97		769,360

Outstanding exercisable - November 30, 2018		150,960,607		$	0.78		3.80	$	565,356